The landscape of dementia prognosis has evolved dramatically with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based checks which will detect Alzheimer's pathology a long time before signs or symptoms emerge. Though these technological advancements signify extraordinary progress in understanding neurodegenerative disorders, they've not https://pault763vfp4.blogsidea.com/profile